Talk:Oxandrolone

Class I and Class II steroids
What are the differences between these classes? Are there more than just two classes of steroids? &mdash;Brim 06:22, 6 November 2005 (UTC)

Is any of this "Abuse being one major problem most bodybuilders consider a normal dose for a novice being 20-30mg's per day when in fact 10 mg is more then enough for someone who never had used" stuff really nessasary. It's becoming quite common on the wikipedia, it pretty useless without some research and there's no evidence to support any of the statements .. lets keep it serious! --81.179.110.164 08:12, 15 August 2007 (UTC)

"Besides the obvious health risks (liver and coronary), the biggest problem with Oxandrolone (and with any anabolic steroid) is of course abuse and addiction. Addiction rate for steroids is so high that the U.S. Controlled Substances Act considers anabolic steroids a Schedule III drug therefore even possession is a felony." Since the American Medical Association, Drug Enforcement Agency,  and NIFA are testified to congress that anabolic steroids are not addictive I this information is incorrect.

There are numerous unreferenced statements and statements that make this sound more like a "how-to" article. The Class 1 vs Class 2 argument is not an accepted scientific theory and should be removedSettersr (talk). —Preceding undated comment was added at 19:32, 11 October 2008 (UTC).

Some grammar issues
"Studies have showed" appears in this article and a few other steroid articles. Maybe my grammar is wrong, but I have always seen, read, and heard, "Studies have shown". I don't think "showed" is proper English. JasonSims1984 (talk) 21:59, 29 December 2014 (UTC)

Unsourced
Too much unsourced stuff here

In contrast with some other steroids with a methyl group in the 17-alpha position, the liver toxicity of oxandrolone is low. Studies have shown that a daily dose of 20 mg oxandrolone used in the course of 12 weeks had only a negligible impact on the increase of liver enzymes. As a DHT derivative, oxandrolone does not aromatize, and thus does not cause gynecomastia. It also does not significantly influence the body's normal testosterone production (HPTA axis) at low dosages (20 mg). When dosages are high, the body reacts by reducing the production of luteinizing hormone after perceiving endogenous testosterone production as too high; this in turn eliminates further stimulation of Leydig cells in the testicles, causing testicular atrophy.
 * Biological effects

- Jytdog (talk) 08:56, 16 June 2016 (UTC)

MEDRS-compliant sources
There are depressingly few MEDRS-compliant sources on oxandrolone because of its spotty and largely historical pharmaceutical availability. However, I have little experience finding primarily medical sources. Does anyone have leads? I shouldn't have problems getting access, but I could use help finding things. William Llewellyn's Anabolics doesn't cite anything particularly useful. Exercisephys (talk) 00:01, 18 June 2016 (UTC)
 * At the very top of the beige (mustard?) box above is a section that provides the link to find reviews at pubmed - it sets you up with a preformatted search that finds reviews published in the last five years. there are plenty! if you need any that are behind a paywall you can ping me with the PMID and I can get it (most, anyway) for you... Jytdog (talk)

Oxandrin capitalization
I partially reverted your edit and re-capitalized Oxandrin because it is a trade name. Also, all sources I could find capitalize it. Exercisephys (talk) 22:34, 18 June 2016 (UTC)
 * Ah thanks. Did not realize that that was also a brandname. Assumed it was a second generic. Doc James  (talk · contribs · email) 15:35, 19 June 2016 (UTC)

"Low" and "medium" doses
I noticed that you replaced the dose ranges I added with the terms "low" and "medium". However, I don't think that these terms carry much meaning. Furthermore, I think that androgen dose ranges are fundamentally different for adolescents and adults (similar to the difference between androgen dose ranges for men and women), so I think using these terms between oxandrolone's use cases is misleading. Finally, I don't recall any indication in the journal articles of whether the doses were "low", "medium", or "high" &mdash; I just remember them sharing numbers.

I'm not trying to start an argument, though. Let me know what you think, and thanks for contributing. Exercisephys (talk) 22:42, 18 June 2016 (UTC)


 * It seems like you're working off of this quote from WP:MEDMOS:


 * "Do not include dose or titration information except when they are extensively discussed by secondary sources, necessary for the discussion in the article, or when listing equivalent doses between different pharmaceuticals."


 * I think that it's worth giving numbers in this case because of how different dose ranges are for children, adolescents, and adults are, and to illustrate the extent to which bodybuilding doses are supraclinical. I'm also confident that the reviews discuss dose enough to justify it. For example, every single study considered by the burn recovery review used 20 mg/day, which seems to be a widely agreed-upon amount. Exercisephys (talk) 22:46, 18 June 2016 (UTC)
 * Yes we are typically hesitant to provide doses as they are tough to keep accurate and we typically consider them too details for a general encyclopedia / we do not want people treating themselves. If you consider them to be of key importance no concern with you restoring them. Doc James  (talk · contribs · email) 15:33, 19 June 2016 (UTC)
 * I strongly object to the dosing, per the policy WP:NOTHOWTO and our implementation of that in WP:MEDMOS.  Am removing. Jytdog (talk) 20:14, 19 June 2016 (UTC)


 * Giving dose ranges has nothing to do with a "how-to" - it illustrates the strongly differing regimens used for different diseases. Also, dosage is well-established and discussed at length in the reviews. Therefore, MEDMOS does not oppose this. Exercisephys (talk) 20:21, 19 June 2016 (UTC)


 * This content absolutely violates policy. Dosing is always discussed in reviews and in the drug label. We do not describe it.   The low/medium/higher aspects can be discussed narratively without giving the actual ranges.  Do not restore this content.  We can take this to some DR process but do not edit war and do not restore it until we are through discussing or dealing with a DR process. Jytdog (talk) 20:40, 19 June 2016 (UTC)


 * You are not taking the time to read and consider the policy. Look at the quote above. Oxandrolone meets two of the exceptional criteria. You are lawyering rather than helping improve the article. Leave my work alone. Exercisephys (talk) 20:46, 19 June 2016 (UTC)
 * Your edit warring is inappropriate. I am too angry to deal rationally with you now so will come back later.  You are completely violating everything Wikipedia is about with your behavior over this content.  I suggest you reconsider what you are doing and especially your attitude with regard to "your work" which is also completely inappropriate.  Jytdog (talk) 20:57, 19 June 2016 (UTC)
 * as Jytdog pointed out we do not give dosing information, please refrain from such edits, thank you--Ozzie10aaaa (talk) 21:11, 19 June 2016 (UTC)
 * As the conveniently above-quoted MoS entry explains, there are exceptions. Those exceptions apply to this article, as I've described at length, but everyone is ignoring that and acting as if the MoS simply says "never give dosage information". Exercisephys (talk) 21:25, 19 June 2016 (UTC)
 * Your claim that I and others are not dealing with MEDMOS is not accurate and has no place here. I do not agree that the dose ranges fall within the exception here.  They don't.  What "high" and "low" means is different for every drug; the exact details of what that means for a given drug is exactly where we don't go - your argument could be made for every single drug article in Wikipedia where there are different indications and different dosing regimes which is not uncommon.Jytdog (talk) 22:18, 19 June 2016 (UTC)


 * Can you stop suggesting that what I'm saying "has no place here", etc.? I am making a very direct and relevant argument, and you're responding with pearl-clutching fluff.
 * I think that dose range differences are relevant in this article and unique when compared to most pharmaceuticals because oxandrolone has idiosyncratic permanent side effects in women and children who take too much. Virilization and premature maturation are interesting and troubling side effects, and the far lower doses given to children illustrate this. It also helps illustrate what an androgen is, how they affect development, and the fact that oxandrolone is one. As per MEDMOS, the reviews I cite spend pages discussing the nuances of dose range selection for this very reason. Exercisephys (talk) 23:35, 19 June 2016 (UTC)

I replied to the first bit here. Every drug has a therapeutic window and side effects as you reach or exceed the upper edge of it. We can wait for others to weigh in here and if more folks don't, we can use a more escalated DR mechanism. In the meantime as consensus develops you should self-revert. You have one "no objection" and two solid opposes, which is definitely consensus for including this. Thanks. Jytdog (talk) 00:35, 20 June 2016 (UTC)


 * Ozzie's objection was a hit-and-run that didn't address the actual topic of discussion. Because he's never edited this article before and because he seemed to just be giving his passing 2¢, I can't help but suspect that you pointed him here.


 * Every drug has a therapeutic window and side effects, few drugs have side effects within common therapeutic ranges that are completely permanent and can greatly effect someone's subjective quality of life. Exercisephys (talk) 01:02, 20 June 2016 (UTC)
 * so...your argument could be made for every single drug article in Wikipedia is the best response on this question, I did not find the dosing information meets any "exception" after reading the article (yesterday), therefore again I object to its placement in the text, as it is inappropriate...IMO--Ozzie10aaaa (talk) 08:29, 20 June 2016 (UTC)
 * More bad faith on your bad part; I posted neutrally at WT:MED per DR to get more voices here and Ozzie is generally quick to respond. Please strike your accusation.    Yes, every drug has side effects, you are making my point there. Jytdog (talk) 01:22, 20 June 2016 (UTC)


 * No indication that this field is exceptional in any way. The blanket ban on providing dosing information should hold. A mention of high, medium, low, very low may be adequate, but numbers are not and should not be given. It is acceptable to point to quality sources that do. Carl Fredrik   💌 📧 08:29, 20 June 2016 (UTC)


 * Once again, there is no "blanket ban" - there is a very clear list of exceptions. Exercisephys (talk) 16:39, 20 June 2016 (UTC)
 * I do understand that you see this as falling within the exceptions. People disagree in WP all the time, and things get bad when both sides won't acknowledge that there is a legitimate disagreement.  Three of us don't agree that this falls within those exceptions and I have explained why I think this so above.  Please acknowledge that.  Thanks Jytdog (talk) 18:33, 20 June 2016 (UTC)
 * When I first started editing here nearly 10 years ago, doses for treatment were presented to me as a nearly blanket ban. Cases to include them should be very few IMO. Doc James  (talk · contribs · email) 20:17, 20 June 2016 (UTC)

Using the initialism AAS
AAS is a common initialism for "anabolic-androgenic steroid". It's convenient because the term "steroid" refers to a far larger class of chemicals, but "anabolic steroid" gets unwieldy and becomes confusing when we're discussing (for example) anabolic-androgenic ratios. AAS is used in many medical sources, so it isn't bodybuilding slang.

Are there any objections to introducing this term early on and using it where possible? Exercisephys (talk) 21:21, 20 June 2016 (UTC)